A detailed history of Avitas Wealth Management LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Avitas Wealth Management LLC holds 29,628 shares of JNJ stock, worth $4.92 Million. This represents 0.64% of its overall portfolio holdings.

Number of Shares
29,628
Previous 36,158 18.06%
Holding current value
$4.92 Million
Previous $5.72 Million 24.29%
% of portfolio
0.64%
Previous 0.88%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 24, 2024

SELL
$144.38 - $157.78 $942,801 - $1.03 Million
-6,530 Reduced 18.06%
29,628 $4.33 Million
Q1 2024

Apr 24, 2024

BUY
$155.22 - $162.74 $67,831 - $71,117
437 Added 1.22%
36,158 $5.72 Million
Q4 2023

Jan 24, 2024

BUY
$145.6 - $158.88 $167,148 - $182,394
1,148 Added 3.32%
35,721 $5.6 Million
Q3 2023

Nov 02, 2023

SELL
$155.75 - $174.48 $42,364 - $47,458
-272 Reduced 0.78%
34,573 $5.38 Million
Q2 2023

Jul 18, 2023

BUY
$154.35 - $166.11 $31,333 - $33,720
203 Added 0.59%
34,845 $5.77 Million
Q1 2023

May 15, 2023

SELL
$151.05 - $180.26 $58,758 - $70,121
-389 Reduced 1.11%
34,642 $5.37 Million
Q4 2022

Jan 10, 2023

SELL
$160.2 - $179.79 $57,191 - $64,185
-357 Reduced 1.01%
35,031 $0
Q3 2022

Oct 27, 2022

SELL
$161.33 - $179.52 $989,114 - $1.1 Million
-6,131 Reduced 14.77%
35,388 $5.78 Million
Q2 2022

Jul 29, 2022

BUY
$168.19 - $186.01 $856,087 - $946,790
5,090 Added 13.97%
41,519 $7.37 Million
Q1 2022

Apr 28, 2022

BUY
$158.14 - $179.59 $206,056 - $234,005
1,303 Added 3.71%
36,429 $6.46 Million
Q4 2021

Jan 26, 2022

BUY
$155.93 - $173.01 $100,262 - $111,245
643 Added 1.86%
35,126 $6.01 Million
Q3 2021

Oct 28, 2021

BUY
$161.5 - $179.47 $11,143 - $12,383
69 Added 0.2%
34,483 $5.57 Million
Q2 2021

Jul 12, 2021

BUY
$159.48 - $171.07 $153,100 - $164,227
960 Added 2.87%
34,414 $5.67 Million
Q1 2021

May 13, 2021

BUY
$153.07 - $170.48 $753,869 - $839,614
4,925 Added 17.26%
33,454 $5.5 Million
Q4 2020

Feb 26, 2021

BUY
$137.11 - $157.38 $78,152 - $89,706
570 Added 2.04%
28,529 $4.49 Million
Q3 2020

Oct 06, 2020

BUY
$140.38 - $153.83 $38,323 - $41,995
273 Added 0.99%
27,959 $4.16 Million
Q2 2020

Jul 30, 2020

SELL
$128.81 - $155.51 $88,621 - $106,990
-688 Reduced 2.42%
27,686 $3.89 Million
Q1 2020

May 13, 2020

BUY
$111.14 - $153.99 $523,913 - $725,908
4,714 Added 19.92%
28,374 $3.72 Million
Q4 2019

Feb 13, 2020

SELL
$127.5 - $146.44 $851,317 - $977,779
-6,677 Reduced 22.01%
23,660 $3.45 Million
Q3 2019

Oct 18, 2019

BUY
$126.95 - $142.14 $3.85 Million - $4.31 Million
30,337 New
30,337 $3.93 Million
Q1 2019

May 01, 2019

SELL
$125.72 - $139.79 $1.27 Million - $1.41 Million
-10,063 Closed
0 $0
Q4 2018

Feb 08, 2019

SELL
$122.84 - $147.84 $2,456 - $2,956
-20 Reduced 0.2%
10,063 $1.3 Million
Q3 2018

Dec 19, 2018

SELL
$121.58 - $142.88 $466,137 - $547,801
-3,834 Reduced 27.55%
10,083 $1.39 Million
Q3 2018

Nov 13, 2018

BUY
$121.58 - $142.88 $570,210 - $670,107
4,690 Added 50.83%
13,917 $1.92 Million
Q2 2018

Aug 13, 2018

BUY
$119.4 - $131.76 $1.1 Million - $1.22 Million
9,227 New
9,227 $1.12 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $434B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Avitas Wealth Management LLC Portfolio

Follow Avitas Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avitas Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avitas Wealth Management LLC with notifications on news.